Identifying T1D patients carrying at-risk alleles in CTLA-4 or FOXO-3 may enable targeted interventions such as optimized vitamin D supplementation, tailored probiotic regimens, stress management strategies, and lifestyle modifications to reduce AITD or MASLD risk. The gene discussed is FOXO3; the disease is type 1 diabetes mellitus.